Georgette M. Castanedo
Genentech · 56 works · 2,079 citations · h-index 22
Top works
- GDC-0449—A potent inhibitor of the hedgehog pathway
- Discovery of (Thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer
- Discovery of a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer
- Discovery of GDC-0853: A Potent, Selective, and Noncovalent Bruton’s Tyrosine Kinase Inhibitor in Early Clinical Development
- Identification of GNE-477, a potent and efficacious dual PI3K/mTOR inhibitor
- Synthesis of tetrasubstituted thiophenes on solid-support using the Gewald reaction
- Rapid Synthesis of 1,3,5-Substituted 1,2,4-Triazoles from Carboxylic Acids, Amidines, and Hydrazines
- Discovery of Novel PI3-Kinase δ Specific Inhibitors for the Treatment of Rheumatoid Arthritis: Taming CYP3A4 Time-Dependent Inhibition
- NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus
- Potent and Highly Selective Benzimidazole Inhibitors of PI3-Kinase Delta
- Corrigendum to “GDC-0449—A potent inhibitor of the hedgehog pathway” [Bioorg. Med. Chem. Lett. 19 (2009) 5576]
- Potent and selective inhibitors of PI3Kδ: Obtaining isoform selectivity from the affinity pocket and tryptophan shelf
- Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K)
- CDK2/cyclinA inhibitors: Targeting the cyclinA recruitment site with small molecules derived from peptide leads
- Selective α4β7 Integrin Antagonists and Their Potential as Antiinflammatory Agents
- Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-κB Inducing Kinase
- Structure-based optimization of pyrazolo-pyrimidine and -pyridine inhibitors of PI3-kinase
- Identification of GNE-293, a potent and selective PI3Kδ inhibitor: Navigating in vitro genotoxicity while improving potency and selectivity
- Abstract DDT02-01: Discovery of GDC-0032: A beta-sparing PI3K inhibitor active against PIK3CA mutant tumors.
- Introduction of Trifluoroethylamine as Amide Isostere by C–H Functionalization of Heteroarenes